seekingalpha.com
/1 month ago
Latest updates for Auph
Fresh curated links around AUPH are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Helus Pharma: APPROACHing Inflection: Pivotal Readout Sets Up Asymmetric Upside
- authID Inc. (AUID) Shareholder/Analyst Call Prepared Remarks Transcript
- Aptevo Provides 2Q26 Business Update and Reports Second Quarter Financial Results
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
seekingalpha.com
/1 month ago
authID Inc. (AUID) Shareholder/Analyst Call Prepared Remarks Transcript
newswire.com
/1 week ago
Aptevo Provides 2Q26 Business Update and Reports Second Quarter Financial Results
Mipletamig Drives Clinical Momentum with Strong Frontline AML Data, Path Toward Phase 2Chief Scientific Officer Appointment Strengthens Execution Across Advancing Oncology Pipeline...
finance.yahoo.com
/1 month ago
Why Auna’s (AUNA) Analyst Upside Depends on Latin American Healthcare Platform Execution
cafepharma.com
/2 weeks ago
ANC
ANC Anonymous (not verified) Tue, 08/04/2026 - 21:28 field_thread_url https://cafepharma.com/boards/threads/anc.712901/ board name...
seekingalpha.com
/1 month ago
Anthropic soon to win U.S. clearance to restore Fable 5: Axios
seekingalpha.com
/1 month ago
Upstart: Promising Recovery Set Up Despite Potentially Lumpy Q2 2026; Reiterate Buy
finance.yahoo.com
/5 days ago
AMLX Stock Soars as Amylyx GLP-1 Drug Succeeds in Late-Stage Trial
newswire.com
/6 days ago
Emerging Growth Research Releases Flash Report on First Phosphate; Reiterates Buy Rating and C$4.94 Price Target Followi...
fool.com.au
/1 month ago
Up 1,511% in a year, guess which ASX uranium share is storming higher again on Wednesday
Investors are piling into this surging ASX uranium stock again today. But why? The post Up 1,511% in a year, guess which ASX uranium share is storming higher again on Wednesday app...
seekingalpha.com
/3 weeks ago
Aurora Innovation: At The Cusp Of Commercialization, But Execution Remains Key (Rating Upgrade)
fool.com.au
/2 weeks ago
Neuren Pharmaceuticals share price rockets: record Q2 DAYBUE sales and royalty upgrade
Second quarter net sales of DAYBUE increased 30%. The post Neuren Pharmaceuticals share price rockets: record Q2 DAYBUE sales and royalty upgrade appeared first on The Motley Fool...
investing.com
/2 weeks ago
Axsome therapeutics CEO Herriot Tabuteau sells $10.5m in shares
seekingalpha.com
/1 month ago
Atlantic Union Bankshares Corporation (AUB) Q2 2026 Earnings Call Transcript
newswire.com
/1 week ago
Aptevo Therapeutics Announces Exercise of Existing Warrants and PIPE for $4.5 Million Gross Proceeds
seekingalpha.com
/1 month ago
ABIVAX Société Anonyme (ABVX) Discusses ABTECT Maintenance Part 2 Results and Updated Obefazimod Safety and Efficacy Dat...
fool.com
/3 days ago
Abeona (ABEO) Q2 2026 Earnings Call Transcript
ZEVASKYN revenue surged 31% to $11.4 million as treatment network expanded.
seekingalpha.com
/1 week ago
Transurban Group Stapled Securities (TRAUF) Q4 2026 Earnings Call Transcript
seekingalpha.com
/3 weeks ago
Ardagh Metal Packaging: EBITDA Outperformance Supports Further Upside
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Auph
seekingalpha.com
Recent coverage from public sources
Public source
cafepharma.com
Recent coverage from public sources
Public source
finance.yahoo.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
fool.com.au
Recent coverage from public sources
Public source